secwatch.observer — SEC 8-K summary
======================================

Issuer:     INVO Fertility, Inc. (IVF)
CIK:        0001417926
Form:       8-K
Filed at:   2026-06-02T12:40:33+00:00
Accession:  0001493152-26-026777
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INVO Fertility FY2025 revenue $6.84M (+5% YoY); net loss improves to $(5.3)M
----------------------------------------------------------------------------

- Revenue $6,841,250, up 5% from $6,532,000; consolidated clinic revenue up 4% to $6.72M.
- Net loss from continuing operations improved to $(5.3)M from $(7.7)M; adjusted EBITDA $(3.2)M vs $(2.2)M.
- Raised $11.5M in gross proceeds from Dec 2025 and Jan 2026 financings; Series C-2 Preferred converted/retired.
- Acquired Indiana-based Family Beginnings in Feb 2026; it had $1.2M revenue and $0.2M net income TTM Sep 2025.
- Patent issued for modified INVOcell device extending protection through 2040; total common shares ~1.8M as of June 2, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417926/000149315226026777/0001493152-26-026777-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417926/000149315226026777/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-026777

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer